Michael Milligan - 24 May 2022 Form 4 Insider Report for Conformis Inc (CFMS)

Role
Director
Signature
/s/ Denise E. Pedulla, Attorney-in-Fact for Michael Milligan
Issuer symbol
CFMS
Transactions as of
24 May 2022
Transactions value $
$0
Form type
4
Filing time
26 May 2022, 14:13:36 UTC
Previous filing
28 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CFMS Common Stock Award $0 +130,870 +107% $0.000000 253,093 24 May 2022 Direct F1
holding CFMS Common Stock 937,500 24 May 2022 See footnote. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of RSAs granted to the Reporting Person pursuant to Conformis' 2015 Stock Incentive Plan. The shares will vest 100% on the one year anniversary of the grant date.
F2 The securities are directly held by NewtrAx LLC, which is indirectly controlled by Lexa International Corporation. The Reporting Person is affiliated with NewtrAx LLC and disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.